Compare IRON & LFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | LFST |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2020 | 2021 |
| Metric | IRON | LFST |
|---|---|---|
| Price | $69.83 | $8.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $103.18 | $9.83 |
| AVG Volume (30 Days) | 384.6K | ★ 2.5M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,424,285,000.00 |
| Revenue This Year | N/A | $17.18 |
| Revenue Next Year | $283.52 | $14.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 13.85 |
| 52 Week Low | $40.00 | $3.74 |
| 52 Week High | $99.50 | $8.89 |
| Indicator | IRON | LFST |
|---|---|---|
| Relative Strength Index (RSI) | 54.12 | 64.15 |
| Support Level | $64.48 | $7.24 |
| Resistance Level | $71.85 | $8.89 |
| Average True Range (ATR) | 3.26 | 0.28 |
| MACD | 0.04 | 0.09 |
| Stochastic Oscillator | 64.61 | 89.24 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.